Determining a novel pathway that controls TGF-beta activation in the immune system.
Determining a novel pathway that controls TGF-beta activation in the immune system.
批准号:
BB/R003114/1
负责人:
Mark Travis
金额:
$58.28万
依托单位:
依托单位国家:
英国
项目类别:
Research Grant
财政年份:
2018
资助国家:
英国
项目状态:
已结题
起止时间:
2018 至 --
中文摘要
免疫系统必须迅速动员起来以消除感染,但要严格调节以防止自我伤害的免疫反应。当这种调节机制失效时,动物和人类可能会出现严重的健康问题,如不受控制的感染或自身免疫性疾病(免疫系统攻击人体自身的组织和器官)。由于免疫系统的调节涉及许多不同的细胞相互沟通,我们必须了解这种沟通中涉及的信号和机制,以了解免疫系统如何维持健康。免疫系统中的一个重要信号是由一种称为转化生长因子-β(TGF-β)的蛋白质提供的。TGF-β是一种抗炎分子,在调节潜在有害的免疫反应中很重要。然而,在某些情况下,TGF-β能够促进有害的免疫反应。因此,了解这个关键分子是如何控制的,对于了解免疫系统是如何正确调节的至关重要。我们最近的工作突出了一个重要的途径,这是至关重要的控制行动的TGF-β在免疫系统中。因此,我们已经证明,一种称为整合素α v β 8的受体,当存在于称为树突状细胞的免疫系统细胞上时,激活TGF-β以抑制肠道中的有害免疫反应。此外,该途径在自身免疫和感染模型期间促进有害的免疫应答中是重要的。因此,整合素α v β 8在控制多种免疫反应中至关重要。然而,目前我们对整合素α v β 8-TGF-β通路如何控制不同类型的免疫应答知之甚少,本提案的目的是确定整合素α v β 8调节免疫应答的全新方式。以前认为这种分子存在于细胞表面。然而,我们现在发现,整合素是从免疫细胞分泌的所谓的“细胞外囊泡”,这是已知的能够促进与免疫系统的其他细胞的通信。我们的建议将定义这一途径的重要性,以及如何控制它。这项工作将使我们更好地了解调节免疫系统以维持健康的生物机制。
英文摘要
The immune system must be rapidly mobilised to eliminate infection, but be tightly regulated to prevent self-harmful immune responses. When this regulation breaks down, severe health problems can occur in animals and humans such as uncontrolled infection or autoimmune disorders (where the immune system attacks the body's own tissues and organs). As regulation of the immune system involves many different cells communicating with each other, it is essential that we understand the signals and mechanisms involved in this communication to understand how the immune system maintains health.An important signal in the immune system is provided by a protein called transforming growth factor-beta (TGF-beta). TGF-beta acts as an anti-inflammatory molecule, important in regulating potentially harmful immune responses. However, in some scenarios TGF-beta is capable of promoting harmful immune responses. Hence, understanding how this key molecule is controlled is essential in understanding how the immune system is properly regulated. Our recent work has highlighted an important pathway that is crucial in controlling the actions of TGF-beta in the immune system. Thus, we have shown that a receptor called integrin alphav beta8, when present on cells of the immune system called dendritic cells, activates TGF-beta to suppress harmful immune responses in the intestine. Additionally, this pathway is important in promoting harmful immune responses during models of autoimmunity and infection. Hence, integrin alphav beta8 is vital in controlling diverse immune responses. However, at present we know very little about how the integrin alphav beta8-TGF-beta pathway controls different types of immune response.The aim of this proposal is to identify a completely new way by which integrin alphav beta8 regulates immune responses. It was previously thought that this molecule is found on the surface of cells. However, we now find that the integrin is secreted from immune cells on so-called 'extracellular vesicles', which are known to be capable of promoting communication with other cells of the immune system. Our proposal will define the importance of this pathway, and how it is controlled. Such work will allow us to better understand the biological mechanisms that regulate the immune system to maintain health.
期刊论文(9)
专著(0)
科研奖励(0)
会议论文
DOI:
10.1126/scitranslmed.aao4755
发表时间:
2018-10-24
期刊:
Science translational medicine
影响因子:
17.1
作者:
[Scott NA, Andrusaite A, Andersen P, Lawson M, Alcon-Giner C, Leclaire C, Caim S, Le Gall G, Shaw T, Connolly JPR, Roe AJ, Wessel H, Bravo-Blas A, Thomson CA, Kästele V, Wang P, Peterson DA, Bancroft A, Li X, Grencis R, Mowat AM, Hall LJ, Travis MA, Milling SWF, Mann ER]
通讯作者:
Mann ER
DOI:
10.4049/jimmunol.2100651
发表时间:
2023-03-01
期刊:
JOURNAL OF IMMUNOLOGY
影响因子:
4.4
作者:
[Dow, Joshua, Cytlak, Urszula M., Casulli, Joshua, McEntee, Craig P., Smedley, Catherine, Hodge, Suzanne H., D'Elia, Riccardo, V, Hepworth, Matthew R., Travis, Mark A.]
通讯作者:
Travis, Mark A.
A novel pathway in the control of memory T cell function during immune responses to viral re-infection.
-
批准号:MR/V011243/1
-
项目类别:Research Grant
-
资助金额:$76.75万
-
财政年份:2021
-
负责人:Mark Travis
-
依托单位:
Identifying a crucial pathway by which regulatory T-cells control immunity via integrin alphavbeta8 and TGF-beta.
-
批准号:MR/M00242X/1
-
项目类别:Research Grant
-
资助金额:$61.62万
-
财政年份:2015
-
负责人:Mark Travis
-
依托单位:
TGF-beta activation by gut dendritic cells: identifying a critical pathway in regulation of chronic parasitic infection
-
批准号:G1001753/1
-
项目类别:Research Grant
-
资助金额:$58.18万
-
财政年份:2011
-
负责人:Mark Travis
-
依托单位:
Regulation of the immune response: the role of integrin alphavbeta8 and TGF-beta in immune homeostasis and response to pathogens.
-
批准号:BB/G001103/1
-
项目类别:Research Grant
-
资助金额:$52.55万
-
财政年份:2008
-
负责人:Mark Travis
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Novel-miR-1134调控LHCGR的表达介导拟
穴青蟹卵巢发育的机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2025
-
负责人:崔文晓
-
依托单位:
miR-2796和novel_13靶向磷脂酶C基因调控Q烟粉虱高温耐受性的分子机制
-
批准号:32402377
-
项目类别:青年科学基金项目
-
资助金额:30.00万元
-
批准年份:2024
-
负责人:戴恬美
-
依托单位:
novel-miR75靶向OPR2,CA2和STK基因调控人参真菌胁迫响应的分子机制研究
-
批准号:82304677
-
项目类别:青年科学基金项目
-
资助金额:30.00万元
-
批准年份:2023
-
负责人:边兴博
-
依托单位:
海南广藿香Novel17-GSO1响应p-HBA调控连作障碍的分子机制
-
批准号:82304658
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:刘亚
-
依托单位:
白术多糖通过novel-mir2双靶向TRADD/MLKL缓解免疫抑制雏鹅的胸腺程序性坏死
-
批准号:32102747
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.0万元
-
批准年份:2021
-
负责人:李婉雁
-
依托单位:
novel_circ_001042/miR-298-5p/Capn1轴调节线粒体能量代谢在先天性肛门直肠畸形发生中的作用机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:55万元
-
批准年份:2021
-
负责人:唐晓冰
-
依托单位:
novel-miR-59靶向HMGAs介导儿童早衰症细胞衰老的作用及机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:58万元
-
批准年份:2021
-
负责人:张瑜
-
依托单位:
novel_circ_008138/rno-miR-374-3p/SFRP4调控Wnt信号通路参与先天性肛门直肠畸形发生的分子机制研究
-
批准号:82070530
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2020
-
负责人:白玉作
-
依托单位:
miRNA-novel-272通过靶向半乳糖凝集素3调控牙鲆肠道上皮细胞炎症反应的机制研究
-
批准号:32002421
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:修云吉
-
依托单位:
m6A修饰介导的lncRNA WEE2-AS1转录后novel-pri-miRNA剪切机制在胶质瘤恶性进展中的作用研究
-
批准号:82072775
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2020
-
负责人:薛皓
-
依托单位: